Mateusz Kaczmarek

Mateusz Kaczmarek is a financial and technology journalist at TS2.tech, covering stocks, artificial intelligence, semiconductors and global market developments. A graduate of the Poznań University of Economics and Business, he previously worked in financial analysis before moving into business journalism. His reporting focuses on technology companies, market trends and the forces shaping global investment markets. Follow Mateusz Kaczmarek on Google News.

Harrison Global Stock Surges on Bitcoin Treasury Strategy and Expansion Plans

Harrison Global Stock Surges on Bitcoin Treasury Strategy and Expansion Plans

Harrison Global Holdings shares jumped about 11–12% on Oct 17, 2025, trading near $0.22 google.com. A pre-market report noted a ~19% spike to $0.23 after hours gurufocus.com. - The company announced on Oct 17 a binding term sheet with White Lion Capital to execute a Bitcoin Purchase Agreement, formally launching a “Bitcoin Treasury Strategy” marketwirenews.com. Harrison says this is meant to diversify its cash reserves and hedge inflation marketwirenews.com. - Investor Sentiment: Technical indicators are mixed. GuruFocus notes BLMZ’s RSI is around 47 and its annualized volatility is very high gurufocus.com gurufocus.com. An AI-based model rates the stock a “Strong Buy”, citing 5 buy vs. 3 sell technical signals, and projects a ~3.5% gain over the next month intellectia.ai intellectia.ai. - Business Expansion: Earlier this week, Harrison unveiled plans to establish a ¥10 billion fund with European partners to promote Korean and Japanese media content in Europe and South America marketwirenews.com. Co-CEO Ryoshin Nakade said the collaboration “will significantly contribute to the expansion of excellent media content … into Europe and South America” marketwirenews.com. On Sept. 19 the company detailed strategic moves including investments in Asian content and biotech marketwirenews.com. - Stock Forecasts: No Wall Street analysts cover BLMZ, but
Achieve Life Sciences Skyrockets on FDA Boost – Is This Nicotine Addiction Breakthrough a Game Changer?

Achieve Life Sciences Skyrockets on FDA Boost – Is This Nicotine Addiction Breakthrough a Game Changer?

Achieve Life Sciences stock exploded higher on the FDA news, reflecting growing optimism around cytisinicline’s prospects. In pre-market trading on Oct. 17, ACHV jumped about 22.7% after the company revealed it received a rare FDA Commissioner’s National Priority Voucher for cytisinicline’s vaping cessation indication investing.com. This rally propelled the shares to multi-month highs in the mid-$3 range. Earlier in the week, ACHV had already begun gaining momentum – on Oct. 15 the stock broke above its 200-day moving average and hit $3.19 marketbeat.com, a bullish technical signal. As of Thursday’s close, the stock was at $3.08, up roughly 10% over the past month and far outperforming the broader market investing.com.
Huntington Bancshares’ Profit Surge Defies Banking Jitters – HBAN Stock Eyes Rebound

Huntington Bancshares’ Profit Surge Defies Banking Jitters – HBAN Stock Eyes Rebound

HBAN shares are attempting a comeback after a volatile week. On October 16, Huntington’s stock slid 5.2% to $15.37 markets.financialcontent.com amid a broader rout in regional bank stocks. Credit jitters hit the sector after a “cockroach” of bad loan news – one mid-sized lender disclosed a fraud-linked loss and another flagged sour commercial loans ts2.tech ts2.tech. The KBW Regional Bank Index plunged ~6.5% that day ts2.tech, dragging down even healthy banks like Huntington.
17 October 2025
Ally Financial Stock Soars on Profit Surge – Analysts Bullish on What’s Next

Ally Financial Stock Soars on Profit Surge – Analysts Bullish on What’s Next

Ally Financial delivered an upside surprise in Q3 2025, powering a relief rally in its stock. The Detroit-based digital bank – a major auto lender and online banking provider – reported third-quarter earnings on October 17 that handily beat expectations. Net income more than doubled year-over-year, rising to $371 million versus $171 million in Q3 2024 nasdaq.com. On an adjusted basis, earnings were $1.15 per share, about 14% above analyst consensus of ~$1.01 chartmill.com. Revenue came in at $2.17 billion, up ~3% from a year ago and slightly ahead of forecasts around $2.11B chartmill.com.
17 October 2025
Biotech Breakthrough: Rani Therapeutics (RANI) Stock Skyrockets on $1B Deal – What Investors Need to Know

Biotech Breakthrough: Rani Therapeutics (RANI) Stock Skyrockets on $1B Deal – What Investors Need to Know

Rani Therapeutics’ stock price skyrocketed on Friday, Oct. 17, after the company unveiled a major partnership and funding news. In pre-market trade, RANI jumped about 150% and continued to rally after the market open tipranks.com. The stock, which had closed at just $0.47 the prior day, briefly hit approximately $1.37 per share – nearly a 3× gain in value google.com. By midday, shares were still trading around the $1.30 level, up almost +180% on the day. This stunning one-day move snapped RANI out of penny-stock territory and back above the Nasdaq’s $1 minimum bid price, easing near-term delisting fears.
Fifth Third’s Stock Jumps on Earnings Beat and Mega-Merger – Is FITB a Buy Now?

Fifth Third’s Stock Jumps on Earnings Beat and Mega-Merger – Is FITB a Buy Now?

Fifth Third’s stock is bouncing back to end a volatile week. By midday Friday, FITB shares were trading around $41–$42, up roughly 2–3% after the bank’s strong earnings report beat expectations reuters.com. The mini-rally follows a sharp selloff in regional bank stocks just one day earlier: on Thursday, Fifth Third fell about 4% as part of a broader rout fueled by credit worries ts2.tech. News of surprise loan losses at two peer banks – Zions and Western Alliance – had spooked investors, dragging the KBW regional banking index down over 6% in its worst drop since April ts2.tech ts2.tech.
SLB Stock Q3 Beat, $4B Buybacks & Oil Swoon: Will Schlumberger (SLB) Rebound?

SLB Stock Q3 Beat, $4B Buybacks & Oil Swoon: Will Schlumberger (SLB) Rebound?

SLB’s third-quarter 2025 results, released on Oct 17, showed better-than-expected profitability even as industry conditions softened. The company earned $0.69 per share for Q3, topping estimates of $0.66 Tipranks. Revenue came in at $8.93 billion, essentially on target Tipranks. Both metrics were down modestly from a year ago as global drilling activity has cooled. CEO Olivier Le Peuch described the quarter as “resilient,” noting SLB expanded its EBITDA margins and generated $1.8 B in free cash flow, thanks to efficiency gains Investing Investing. North America proved a bright spot – revenue there rose +14% YoY to $1.93 B as the U.S. rig count stabilized Reuters Reuters. International revenue fell 7% YoY to $6.92 B amid lower spending in regions like Latin America and Europe Reuters. Le Peuch noted that high oil inventories and geopolitical uncertainties made overseas customers cautious on short-cycle projects Investing Investing.
American Express Raises Forecasts Amid Spending Boom – Is AXP Stock Poised to Soar?

American Express Raises Forecasts Amid Spending Boom – Is AXP Stock Poised to Soar?

American Express shares have been on a tear in recent months. The stock surged roughly 50% off its April lows following market jitters over tariffs, ultimately reaching a record high of $349.19 earlier this month Schwabnetwork. After peaking, AXP saw a quick 9.5% pullback over 14 trading days to around $315, before buyers stepped in. Notably, a single-session jump of +3% on Tuesday, October 14 helped break the downtrend and lifted the stock back above its 21-day moving average near $329 Schwabnetwork. As of October 17, AXP hovers around the $330 level, putting it within striking distance of its best levels of the year.
Kenvue (KVUE) Stock Plummets to Record Low Amid Talc Lawsuit and Tylenol Scare

Kenvue (KVUE) Stock Plummets to Record Low Amid Talc Lawsuit and Tylenol Scare

Kenvue’s shares collapsed to an all-time low since their mid-2023 IPO, closing around $14 after Thursday’s 13.2% plunge stocktwits.com. The one-day drop – Kenvue’s worst on record – was triggered by headline risks that blindsided investors. By early Friday, October 17, the stock stabilized slightly after the rout stocktwits.com. Still, at roughly 40% below its IPO price, the Johnson & Johnson spinoff has seen its market capitalization shrink to about $30–31 billion reuters.com.
Akanda Corp (AKAN) Soars on Telecom Expansion – What It Means for Investors

Akanda Corp (AKAN) Soars on Telecom Expansion – What It Means for Investors

Akanda’s stock has been on a rollercoaster. After languishing through 2024 “flying under the radar” stocktitan.net, AKAN came alive this October. The share price erupted over 100% intraday on Oct. 1 amid a burst of interest in the company’s new direction stocktitan.net. Traders cite the ultra-low float – under 0.73 million shares – as a catalyst for these outsized swings. When positive news hits a micro-cap with so few shares available, “even modest buying pressure can create explosive moves” stocktitan.net. Conversely, any wave of selling can also trigger sharp pullbacks, making AKAN a volatile ride.
17 October 2025
Jefferies Stock Plunge Deepens Amid Bankruptcy Fallout – Will a Rebound Follow?

Jefferies Stock Plunge Deepens Amid Bankruptcy Fallout – Will a Rebound Follow?

Jefferies shares have been on a wild ride in recent weeks, culminating in a steep plunge on October 16. The stock sank intraday to about $50 – territory not seen in over four months – before closing at $48.80, down over 10% for the day stockinvest.us. The selloff erased roughly one-quarter of Jefferies’ market value in just two weeks, capping a slide from the mid-$60s in late September ts2.tech.
17 October 2025
Safe & Green (SGBX) Roars Back: Nasdaq Lifeline and AI Pivot Fuel Wild Stock Ride

Safe & Green (SGBX) Roars Back: Nasdaq Lifeline and AI Pivot Fuel Wild Stock Ride

A week ago, Safe & Green Holdings Corp. was on the brink of losing its Nasdaq listing – today it’s back in the game, though not without turbulence. The Miami-based modular building and green construction company secured a lifeline on Oct. 9 by regaining compliance with Nasdaq’s $1 minimum bid price requirement, after drastic capital moves to bolster its share price ts2.tech. Nasdaq confirmed the company met listing rules as of Oct. 3, following a reverse 1-for-64 stock split and a major deal restructuring that avoided issuing over 1 billion new shares for a planned acquisition stockstotrade.com stockstotrade.com. These bold actions averted “a proverbial sword hovering above” the company’s stock stockstotrade.com, according to market commentators, and immediately sparked a relief rally.
Mortgage Rates Hit 2025 Low at 6.27% – Will They Finally Dip Below 6%?

Mortgage Rates Hit 2025 Low at 6.27% – Will They Finally Dip Below 6%?

Mortgage rates have dipped to their lowest levels in about a year, offering American homebuyers a measure of relief after the steep run-up of the past two years. Freddie Mac’s latest survey shows the average 30-year fixed rate at 6.27%, down from 6.3% last week foxbusiness.com. This is just above the year’s low reached a month ago and the lowest since early October 2024 apnews.com. By comparison, rates were roughly 6.44% a year ago and had peaked just above 7% in January apnews.com, so borrowing costs are off their highs, albeit still high historically. The 15-year fixed mortgage also ticked down to about 5.52% foxbusiness.com, offering cheaper refinancing options for some homeowners.
17 October 2025
Nasdaq Warning and EV Ambitions: Carbon Revolution (CREV) Races to Reinvent Itself

Nasdaq Warning and EV Ambitions: Carbon Revolution (CREV) Races to Reinvent Itself

Carbon Revolution is under intense pressure to shore up its Nasdaq listing status. On July 16, the Australia-based company disclosed it had received a non-compliance notice for falling short of Nasdaq’s minimum shareholder equity requirement of $10 million stocktitan.net. The deficiency was evident in its FY2024 financials, and Nasdaq gave Carbon Revolution 45 days to submit a plan to regain compliance stocktitan.net. If that plan is accepted, the company could get up to 180 days to rebuild its equity base or otherwise meet listing standards stocktitan.net. Failure to do so would put Carbon Revolution at risk of delisting from the Nasdaq Global Market.
Fraud Scandals Spark Market Selloff as ‘Cockroach’ Credit Fears Mount

Fraud Scandals Spark Market Selloff as ‘Cockroach’ Credit Fears Mount

Wall Street skidded into the red late this week as fear of hidden loan losses gripped the market. On Thursday, the Dow, S&P 500, and Nasdaq all closed sharply lower – around 0.5%–1% down each for the day reuters.com – after early gains evaporated. The Dow Jones index gave up roughly 300–400 points, about 0.65%, by the closing bell reuters.com. The reversal came suddenly after midday news of loan problems at two regional banks hit traders’ screens. “Signs of weakness in regional banks spooked investors already on edge,” Reuters noted, especially as U.S.–China trade tensions and other uncertainties were already weighing on sentiment reuters.com.
Artiva Biotherapeutics (ARTV) Stock Skyrockets on FDA Fast Track News – What’s Next for Investors?

Artiva Biotherapeutics (ARTV) Stock Skyrockets on FDA Fast Track News – What’s Next for Investors?

In summary, Artiva Biotherapeutics stock has erupted in October 2025 on the back of a major FDA Fast Track win and renewed optimism around its NK-cell therapy for RA. The latest developments – from surging share price and volume to analyst projections of multi-fold upside – underscore the high stakes and high hopes riding on AlloNK’s success. For biotech investors and observers, ARTV will be a stock to watch closely in the coming months, as upcoming trial data and FDA feedback chart the next chapter for this promising yet still speculative biotech play.
17 October 2025
Truist’s Q3 Earnings Beat and 5% Dividend Yield Trigger Rally as Analysts Grow Bullish

Truist’s Q3 Earnings Beat and 5% Dividend Yield Trigger Rally as Analysts Grow Bullish

Truist’s third-quarter results breezed past expectations, providing a jolt of good news for the regional banking sector. Net income available to common shareholders came in at $1.35 billion, exceeding analysts’ $0.99 forecast investing.com and slightly above $0.99 in the prior-year quarter. Revenue of $5.24 billion was roughly in line with estimates investing.com, as strong fee-based income made up for softer interest income. “Truist delivered strong third-quarter results, underscored by robust fee income growth in investment banking and trading and wealth, healthy loan expansion, and continued expense and credit discipline,” said CEO Bill Rogers in the earnings release investing.com.
Regional Bank Fraud Scare Sparks Panic – Is a Fed Rate Cut on the Horizon?

Regional Bank Fraud Scare Sparks Panic – Is a Fed Rate Cut on the Horizon?

Mid-sized banks shocked Wall Street this week with alarming disclosures of bad loans. Zions Bancorporation – a Utah-based regional lender – stunned investors by announcing a $50 million charge-off tied to two commercial loans that it says were compromised by fraud theguardian.com. In an SEC filing, Zions reported “misrepresentations and contractual defaults” by the borrowers and moved to accelerate the loans to default and sue the guarantors ts2.tech ts2.tech. Western Alliance, a Phoenix-based peer, also revealed it is dealing with a fraudulent borrower, having filed a lawsuit back in August after the client allegedly used fake collateral theguardian.com ts2.tech. These back-to-back fraud bombshells amplified scrutiny of regional banks’ lending practices and risk controls, fueling concern that similar hidden problems could be lurking elsewhere ts2.tech ts2.tech. “Hidden credit stress” is how one Reuters report described the market’s mood – essentially investors wondering if this was just the first cockroach out of the pantry ts2.tech.
Solana’s $195 Lifeline: Can Bulls Turn This Dip Into a $250+ Comeback Rally?

Solana’s $195 Lifeline: Can Bulls Turn This Dip Into a $250+ Comeback Rally?

October started with a bang for Solana – the coin surged roughly 25% in early “Uptober,” briefly spiking above $250 around Oct. 6 ts2.tech. That marked Solana’s strongest price since January and capped a massive run-up from its 2024 lows. The rally was fueled by broad crypto momentum and anticipation of Solana ETF approvals, along with big institutional buys. By mid-month, however, SOL lost steam. After peaking near $240–$250, it reversed sharply, slipping below $220 and even $200 as traders took profits ts2.tech ts2.tech. As of Oct. 17, Solana hovers in the high-$180s – roughly 17% below its early-month peak ts2.tech ts2.tech.
17 October 2025
SoFi’s Roller-Coaster Rally: Fintech Stock Soars 230% in 2025 – What’s Next for SOFI?

SoFi’s Roller-Coaster Rally: Fintech Stock Soars 230% in 2025 – What’s Next for SOFI?

After a spectacular rally through 2025, SoFi’s share price has been on a roller coaster in recent weeks. The stock more than tripled in the past year, climbing from the single digits to a high of about $30.30 by late September ts2.tech. That ~230% year-over-year gain far outpaced most fintech and bank stocks. However, the euphoria has cooled slightly in October: SoFi pulled back roughly 10% from its peak, trading in the mid-$20s as some investors took profits ts2.tech.
17 October 2025
1 98 99 100 101 102 164

Stock Market Today

  • Bitcoin Moves Higher Amid Ceasefire Hopes, but Iran Tensions Persist
    July 26, 2026, 1:58 PM EDT. Analysts expected a crypto rebound as optimism over an Iran ceasefire grew, causing Brent crude to fall 10% to $87 and pushing Bitcoin (BTC) up 0.8%. The $65,000 resistance for Bitcoin remains important, with current sentiment holding steady. Still, Iranian negotiations with the US have come to a halt on discussions about reopening the key oil corridor, the Strait of Hormuz, leaving oil prices high and regional tensions unresolved.